|Articles|May 7, 2019
RPG and WuXi CDS Rebrand as WuXi Clinical
Advertisement
Research Point Global and WuXi Clinical Development Services have announced that they will rebrand as WuXi Clinical at DIA 2019 in San Diego, CA. The newly combined CRO specializes in collaborative partnering for global clinical trials, and prides itself in its extremely patient-centric approaches.
For mor informaton click
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
2
ACT Brief: Tavneos Trial Integrity Issues, Selective Safety Data Regulatory Pathways, and FDA PreCheck Program Launch
3
ACT Brief: Real-Time Trial Infrastructure Gaps, Built-In Data Security, and AI-Enabled CDMO Value
4
Real-Time Clinical Trials: What the FDA's Push Toward Continuous Oversight Means for Sponsors
5